Arthritis during interferon beta-1b treatment in multiple sclerosis

Altintas A., Alici Y., Melikoglu M., Siva A.

MULTIPLE SCLEROSIS, cilt.8, ss.534-536, 2002 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 8 Konu: 6
  • Basım Tarihi: 2002
  • Doi Numarası: 10.1191/1352458502ms852xx
  • Sayfa Sayısı: ss.534-536


Interferon beta (IFN-beta) is the most widely prescribed disease-modifying drug for multiple sclerosis (MS). Therapy with IFN-beta may be associated with a number of adverse reactions. The development or exacerbation of other autoimmune diseases is a rare but reported side effect of IFN-beta therapy. In this case report, we present clinical and laboratory findings of two MS patients who developed arthritis during IFN-beta1b treatment probably of autoimmune origin.